Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Annals of the rheumatic diseases. 2020;79(7):988-90. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies. Annals of the rheumatic diseases. 2020;79(7):988-90.

28/02/2022

Sanchez-Piedra C, Diaz-Torne C, Manero J, Pego-Reigosa JM, Rúa-Figueroa Í, Gonzalez-Gay MA, et al.

Epub 2020/06/07. doi: 10.1136/annrheumdis-2020-217948. PubMed PMID: 32503857; PubMed Central PMCID: PMCPMC7307213.